Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of GT198301474ApublicationCriticalpatent/GT198301474A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
SE DESCRIBEN NUEVAS COMPOSICIONES ANTIDIABETICAS POR VIA ORAL. ESTAS COMPOSICIONES FARMACEUTICAS IMPLICAN LA UTILIZA CION SIMULTANEA DE DOS COMPUESTOS QUIMICOS ORGANICOS DIFERENTES SELECCIONADOS CADA UNO DE ELLOS ENTRE CLASES DISTINTAS DE AGENTES HIPOGLICEMICOS CONOCIDOS, UNA CLASE DE AGENTES IMPLICA A CIERTOS COMPUESTOS CONOCIDOS DE OXAZOLIDIN 2,4DIONA (A) DE ESTRUCTURA QUIMICA CONTENIDA EN LA FICHA TECNICA RESPECTIVA.NEW ANTIDIABETIC COMPOSITIONS ARE DESCRIBED VIA ORAL. THESE PHARMACEUTICAL COMPOSITIONS INVOLVE THE SIMULTANEOUS USE OF TWO DIFFERENT SELECTED ORGANIC CHEMICAL COMPOUNDS EACH OF THEM BETWEEN CLASSES DIFFERENT FROM SINGLE-CLAUGHED CLINICS, A CLASS OF CITIZEN ISSUES WITH COMPOSITE CITIZEN ISSUES, RESPECTIVE TECHNICAL SHEET.